Kewaunee Scientific Corp

Análisis de la acción Kewaunee Scientific Corp (KEQU)

$32.925

+0.751 (+2.28%)Al cierre

Loading chart…
Máximo
33.135
Apertura
33.135
Precio medio ponderado por volumen
32.99
Volumen
1.33K
Capitalización
122.74M
Mínimo
32.925
Importe
44.02K
EV/EBITDA, TTM
0.00

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.

kewaunee.com

Análisis de IA of Kewaunee Scientific Corp (KEQU)

Mantener

Kewaunee Scientific Corp is not a strong buy at the moment due to declining profitability and revenue, despite a low forward P/E of 7.716, indicating potential value. The current RSI of 38.604 suggests the stock is nearing oversold territory, but the recent 1-year change of -18.36% raises concerns about its stability. The main risk is the decline in Q4 profit to $3.39 million, down from $4.85 million last year, which may affect investor confidence moving forward.

Recomendaciones de analistas (1)

Comprar
1 Comprar
0 Mantener
0 Vender
Actual: 32.93
Mínimo
—
Promedio
—
Máximo
—

Métricas de valoración

El PER previsto actual de Kewaunee Scientific Corp (KEQU) es 7.72, frente a su media de 5 años de 12.75.

PER previsto

Valor razonable
Media 5A P/E
12.75
P/E actual
7.72
Sobrevalorada
19.62
Infravalorada
5.88

EV/EBITDA previsto

Muy infravalorado
Media 5A EV/EBITDA
9.42
EV/EBITDA actual
0.00
Sobrevalorada
13.69
Infravalorada
5.14

Precio/ventas previsto

Infravalorado
Media 5A P/S
0.54
P/S actual
0.00
Sobrevalorada
0.82
Infravalorada
0.26

Escenarios de precio de Alphio AI para KEQU

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%KEQU

$74.07

Precio del escenario

B

Base

Base · 50%KEQU

$63.47

Precio del escenario

B

Bajista

Bajista · 25%KEQU

$57.33

Precio del escenario

Cronología de eventos

2026-09-09 (ET)

19:30:00

US Indices Down for Third Day as Oil Prices Rise

16:30:00

Kewaunee Reports Q1 Revenue of $66.32M

2026-06-23 (ET)

17:30:00

Kewaunee Reports Q4 Revenue of $71.4M

2026-03-11 (ET)

16:10:00

Kewaunee Reports Q3 Revenue of $69.4M, Successfully Acquires Nu Aire

2025-09-10 (ET)

16:11:48

Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year

Noticias

Preguntas frecuentes sobre KEQU, respondidas por Alphio AI

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. It operates in the Industrials sector (LABORATORY APPARATUS & FURNITURE industry).

Kewaunee Scientific Corp is not a strong buy at the moment due to declining profitability and revenue, despite a low forward P/E of 7.716, indicating potential value. The current RSI of 38.604 suggests the stock is nearing oversold territory, but the recent 1-year change of -18.36% raises concerns about its stability. The main risk is the decline in Q4 profit to $3.39 million, down from $4.85 million last year, which may affect investor confidence moving forward.

1 analysts cover KEQU: 1 rate it Buy, 0 Hold and 0 Sell.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar